Lemieux nouveau CFO at Nuvo
This article was originally published in Scrip
Executive Summary
Canadian specialty pharmaceutical company Nuvo Research, which is building a portfolio for the topical treatment of pain, has appointed Stephen Lemieux vice-president and chief financial officer following the resignation of James Moulds. Mr Lemieux was previously vice-president of finance and corporate controller at Nuvo. Mr Moulds, who joined the company in 2006, has left to pursue other opportunities.